Olga Chernoloz

School of Psychology, University of Ottawa, Ottawa, ON, Canada.

2 papers in the library · 11 citations · publishing 2024-2025

Papers

Expert recommendations for Germany’s integration of psychedelic-assisted therapy

BMC Medical Education October 24, 2024 Susanne Birnkammer, Olga Chernoloz, Sergio R Pérez Rosal et al. 10 citations

As psychedelic-assisted therapy (PAT) advances to phase III trials in the USA, Europe, particularly Germany, must develop professional education and regulatory frameworks to catch up. Australia has already approved MDMA and psilocybin for mental health, Ukraine is exploring MDMA for war-related PTSD, and Switzerland restarted restricted medical use of MDMA and LSD around 2014, establishing precedents for nations where these substances were illicit. Key challenges include practitioner training standards, accessibility, and oversight. The paper outlines ethical considerations, training protocols, and governmental roles for building infrastructure in Germany to support PAT rollout, aiming to influence broader European policy and help Europe reclaim its historical lead in psychiatric innovation.

DOI: 10.1186/s12909-024-06141-3 Full text Medical education Medline Psychology Medicine

The Potential Economic and Public Health Impact of MDMA‐Assisted Group Therapy for PTSD in Ukraine

World Medical & Health Policy August 21, 2025 Elliot Marseille, Olga Chernoloz, О. И. Орлов 1 citation

Providing group MDMA-assisted therapy (MAT) with supplemental individual sessions for PTSD in Ukraine is likely cost-effective and could save lives. Modeling 1000 patients, treatment costs $1.1 million, averts 19.2 deaths, and gains 717 quality-adjusted life years (QALYs) over 3 years. From a healthcare payer perspective, MAT costs $1537 per QALY gained, considered cost-effective. From a societal perspective, it generates net savings of $2.6 million. Scaling to half of eligible patients over 10 years could save 48,000 lives and gain 1.5 million QALYs, with net societal savings of $5.6 billion. The findings support including MAT in Ukraine's mental health strategy.

DOI: 10.1002/wmh3.70039 MDMA Group psychotherapy Public health Group periodic table +6